Cross Country Healthcare (CCRN) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 11, 2026, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 10, 2026.

Voting matters and shareholder proposals

• Election of six directors for terms expiring at the 2027 annual meeting, with all nominees recommended by the board.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote to approve 2025 executive compensation (say-on-pay).

• Approval of amendment and restatement of the 2024 Omnibus Incentive Plan.

• Proxies may vote on other business as may properly come before the meeting.

Board of directors and corporate governance

• Six director nominees listed: Kevin C. Clark, Dwayne Allen, Venkat Bhamidipati, W. Larry Cash, Gale Fitzgerald, Janice E. Nevin, M.D., MPH.